Sanket Trivedi - Par Drugs Company Officer

PAR Stock   288.35  4.15  1.42%   

Insider

Sanket Trivedi is Company Officer of Par Drugs And
Age 34
Address 816, Nilamber Triumph, Vadodara, India, 390007
Phone91 26 5299 1022
Webhttps://www.pardrugs.com

Par Drugs Management Efficiency

The company has return on total asset (ROA) of 0.1384 % which means that it generated a profit of $0.1384 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2084 %, meaning that it generated $0.2084 on every $100 dollars invested by stockholders. Par Drugs' management efficiency ratios could be used to measure how well Par Drugs manages its routine affairs as well as how well it operates its assets and liabilities. As of November 27, 2024, Total Assets is expected to decline to about 763.9 M. In addition to that, Non Current Assets Total is expected to decline to about 311.6 M
Par Drugs And (PAR) is traded on National Stock Exchange of India in India and employs 122 people. Par Drugs is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Par Drugs And Leadership Team

Elected by the shareholders, the Par Drugs' board of directors comprises two types of representatives: Par Drugs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Par. The board's role is to monitor Par Drugs' management team and ensure that shareholders' interests are well served. Par Drugs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Par Drugs' outside directors are responsible for providing unbiased perspectives on the board's policies.
Jignesh Savani, CEO Director
Chintan Chauhan, Chief Officer
Ghanshayambhai Savani, Whole Director
Sanket Trivedi, Company Officer
Falgun Savani, Chairman MD

Par Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Par Drugs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Par Stock

Par Drugs financial ratios help investors to determine whether Par Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Par with respect to the benefits of owning Par Drugs security.